Jason Zemansky
Stock Analyst at B of A Securities
(4.85)
# 270
Out of 4,496 analysts
24
Total ratings
76.47%
Success rate
45.76%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $83 | $75.97 | +9.25% | 6 | Jul 5, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $2.39 | +4.60% | 4 | Jun 20, 2024 | |
| CYTK Cytokinetics | Maintains: Neutral | $70 → $60 | $56.41 | +6.36% | 3 | May 23, 2024 | |
| ALVR AlloVir | Downgrades: Underperform | $17 → $1 | $0.74 | +34.28% | 2 | Dec 26, 2023 | |
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $29 | $23.08 | +25.65% | 1 | Oct 25, 2023 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $21 → $23 | $14.28 | +61.06% | 2 | Sep 5, 2023 | |
| KURA Kura Oncology | Initiates: Buy | $31 | $20.95 | +47.97% | 1 | Aug 11, 2023 | |
| RPHM Reneo Pharmaceuticals | Initiates: Buy | $23 | $1.48 | +1,454.05% | 1 | Jul 3, 2023 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $2.72 | +267.65% | 3 | May 12, 2023 | |
| ALLK Allakos | Maintains: Buy | n/a | $0.69 | - | 1 | Dec 13, 2021 |
Insmed
Jul 5, 2024
Maintains: Buy
Price Target: $83
Current: $75.97
Upside: +9.25%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $2.39
Upside: +4.60%
Cytokinetics
May 23, 2024
Maintains: Neutral
Price Target: $70 → $60
Current: $56.41
Upside: +6.36%
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17 → $1
Current: $0.74
Upside: +34.28%
Syndax Pharmaceuticals
Oct 25, 2023
Initiates: Buy
Price Target: $29
Current: $23.08
Upside: +25.65%
Arcus Biosciences
Sep 5, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $14.28
Upside: +61.06%
Kura Oncology
Aug 11, 2023
Initiates: Buy
Price Target: $31
Current: $20.95
Upside: +47.97%
Reneo Pharmaceuticals
Jul 3, 2023
Initiates: Buy
Price Target: $23
Current: $1.48
Upside: +1,454.05%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $2.72
Upside: +267.65%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: n/a
Current: $0.69
Upside: -